NTRK Fusion Detection

NTRK fusions are critical events in cancer genomics and are notoriously difficult to detect. Archer® FusionPlex® next-generation sequencing (NGS) RUO tests provide sensitive NTRK fusion detection without prior knowledge of fusion partners.

Archer FusionPlex NGS Assays

Comprehensive Fusion Detection

Anchored Multiplex PCR (AMP™) chemistry utilizes open-ended targeted amplification to identify gene fusions whether or not the fusion partner is known.

simple, lyophilized workflow

Easy-to-handle lyophilized reagents and a simple workflow minimize errors and reduce turn-around time.

Analysis

Be confident in your results by using Archer Analysis. A simple user interface provides in-line visualization and clear reporting. Analysis also allows for third party integration and deploys securely to the cloud or on a local server.

NTRK-CONTAINING

FusionPlex Panels

  • 14 Genes
  • .5M Reads
  • 75 Genes
  • 3M Reads
  • 53 Genes
  • 3M Reads

Build your own or modify any of the above assays.

  • 4-5 Weeks
Get Started With

FusionPlex NGS Assays

Contact your Archer representative today

Ask about our starter panels and wet lab training by Archer field scientists.

You are now leaving archerdx.com. Links to sites outside of ArcherDX are provided as a resource to the viewer. ArcherDX accepts no responsibility for the content of linked sites. 

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.

We won’t track your information when you visit our site. But in order to comply with your preferences, we’ll have to use just one tiny cookie so that you’re not asked to make this choice again.